News
Moving biomedical discoveries from federal laboratories into real-world use depends on productive partnerships, but increasingly those partnerships must also account for research security, data protection and national security risks. At Innovation for Impact: A National Security Technology Transfer

Neglected diseases affect approximately 1 billion people, primarily in developing countries. However, since most R&D is not focused on neglected diseases, very few new treatments are brought to market. Through its partnerships with international public and private institutions, the NIH Office of

On March 15, 2006, the Meningitis Vaccine Project and the Serum Institute of India announced the successful completion of Phase I clinical trials of a new conjugate vaccine against meningitis A, a bacterium that causes deadly epidemics in sub-Saharan Africa. According to the Meningitis Vaccine

A team headed by Dr. Jeffrey Rubin of the National Cancer Institute has received the 2006 Award for Excellence in Technology Transfer from the Federal Laboratory Consortium for Technology Transfer (FLC). The FLC is a nationwide network of over 700 federal laboratories and centers, organized in 1974